Renasant Bank Gilead Sciences, Inc. Transaction History

Renasant Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $559,503 - $610,429	-7,567 Reduced 71.34%	3,040 $227,000
Q2 2023 Aug 01, 2023	SELL	$76.01 - $86.7 $254,709 - $290,531	-3,351 Reduced 24.01%	10,607 $817,000
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $79,551 - $90,634	-1,029 Reduced 6.87%	13,958 $1.16 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $255,387 - $366,648	-4,098 Reduced 21.47%	14,987 $1.29 Million
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $37,688 - $43,050	-633 Reduced 3.21%	19,085 $1.18 Million
Q2 2022 Aug 03, 2022	BUY	$57.72 - $65.01 $63,030 - $70,990	1,092 Added 5.86%	19,718 $1.22 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $240,136 - $300,916	4,146 Added 28.63%	18,626 $1.11 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $425,093 - $482,489	6,552 Added 82.64%	14,480 $1.05 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $184,455 - $199,006	2,725 Added 52.37%	7,928 $553,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $1,332 - $1,456	-21 Reduced 0.4%	5,203 $358,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $51,660 - $58,944	-861 Reduced 14.15%	5,224 $338,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $344,715 - $392,786	6,085 New	6,085 $355,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

Stay updated on Renasant Bank with notifications on news.